DUBLIN--(BUSINESS WIRE)--The "Immunohistochemistry Market Analysis by Product (Equipment, Antibodies, Reagents, Kits), by Application (Research, Diagnostic Applications), by End User (Academic & ...

The advancement in the field of immunotherapeutics has led to a new drive to comprehend the tumor microenvironment. Immunohistochemistry is a robust tool for the investigation of the expression, ...

The global immunohistochemistry (IHC) market is poised for significant growth, with an expected value of USD 3.5 billion in 2024. With a projected moderate compound annual growth rate (CAGR) of 7.8%, ...

Prostate cancer is a complex disease with multiple tumors originating independently at different stages of growth. Despite the identification of key morphological differences between individual tumor ...

The importance of building a validation structure within your lab cannot be overstated. Once in place, the ability to identify high-quality specific results compared to spurious, non-specific antibody ...

insights from industryDr. Will HowatHead of Imaging & Immunohistochemistry Abcam An interview with Dr. Will Howat from Abcam at SfN 2018, discussing the possibilities and challenges of ...

Hepatitis B and C positivity rates in solid tumors and reactivation rates due to cytotoxic chemotherapy.

Personalized medicine depends on tools, such as immunohistochemistry (IHC), that identify precise targets in a patient’s disease. Immunohistochemistry (IHC) staining is integral in developing ...